🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Chongqing

← All China trials

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

5
Recruiting now
8
Active studies
Recruiting Phase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Smoking
Eli Lilly and Company · started 2025-11-03
📍 Beijing · Chengdu · Chongqing · Hangzhou · Linhai · Ningbo
NCT07223840 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Janssen Research & Development, LLC · started 2025-10-01
📍 Beijing · Changzhou · Cheng Du Shi · Chongqing · Foshan · Fuzhou
NCT07196748 on ClinicalTrials.gov ↗
Recruiting Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb · started 2025-09-22
📍 Bengbu · Beijing · Chongqing · Fuzhou · Guangzhou · Shenzhen
NCT07116967 on ClinicalTrials.gov ↗
Active Phase 2
A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B
Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd. · started 2025-09-02
📍 Hefei · Beijing · Sichuan · Chongqing · Fuzhou · Guangzhou
NCT07135349 on ClinicalTrials.gov ↗
Recruiting Phase 3
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. · started 2025-04-30
📍 Beijing · Chongqing · Guangzhou · Shijiazhuang · Changsha · Xuzhou
NCT06937944 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China · started 2025-03-03
📍 Hefei · Chongqing · Fuzhou · Guangzhou · Nanning · Guiyang
NCT06882057 on ClinicalTrials.gov ↗
By invitation Phase 3
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
UCB Biopharma SRL · started 2022-02-03
📍 Beijing · Changchun · Chengdu · Chongqing · Fuzhou · Guangzhou
NCT05076617 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Medullary Thyroid Cancer
Loxo Oncology, Inc. · started 2020-02-11
📍 Hefei · Beijing · Chongqing · Fuzhou · Lanzhou · Guangzhou
NCT04211337 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2
Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/city/chongqing (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.